circZNF707 promoted glycolysis and tumor progression through miR-668-3p-PFKM axis in NSCLC

Wei Chen1,2, Shuai Fang1, Xianqiao Wu1,2

  • 1Thoracic Surgery Department, The First Affiliated Hospital of Ningbo University, No.247 Renmin Road, Ningbo, 315020, Zhejiang Province, People's Republic of China.

PubMed
Abstract

Insights

Circular RNA ZNF707 (circZNF707) promotes non-small cell lung cancer (NSCLC) progression by enhancing cell proliferation, migration, and glycolysis. This circRNA may offer new diagnostic and therapeutic strategies for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in human cancer development.
  • The specific roles and mechanisms of circRNAs in non-small cell lung cancer (NSCLC) are not well understood.

Purpose of the Study:

  • To investigate the role and mechanism of circZNF707 in non-small cell lung cancer (NSCLC).

Main Methods:

  • Microarray analysis identified differentially expressed circRNAs in NSCLC tissues.
  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) measured circZNF707 expression.
  • Loss-of-function and gain-of-function assays assessed NSCLC cell behavior.
  • Western blotting, RIP, qRT-PCR, and luciferase assays elucidated the molecular mechanism.

Main Results:

  • circZNF707 expression was significantly upregulated in NSCLC tissues.
  • circZNF707 promoted NSCLC cell proliferation, migration, invasion, and glycolysis.
  • circZNF707 acts as a molecular sponge for miR-668-3p, upregulating PFKM and driving NSCLC progression.

Conclusions:

  • The circZNF707/miR-668-3p/PFKM axis promotes NSCLC tumor development.
  • circZNF707 presents potential as a biomarker for NSCLC diagnosis and a therapeutic target.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K